Literature DB >> 16740705

A critical role for the inflammatory response in a mouse model of preneoplastic progression.

Kathryn L Schwertfeger1, Wa Xian, Alan M Kaplan, Sandra H Burnett, Donald A Cohen, Jeffrey M Rosen.   

Abstract

The tumor microenvironment, which includes inflammatory cells, vasculature, extracellular matrix, and fibroblasts, is a critical mediator of neoplastic progression and metastasis. Using an inducible transgenic mouse model of preneoplastic progression in the mammary gland, we discovered that activation of inducible fibroblast growth factor receptor-1 (iFGFR1) in the mammary epithelium rapidly increased the expression of several genes involved in the inflammatory response. Further analysis revealed that iFGFR1 activation induced recruitment of macrophages to the epithelium and continued association with the alveolar hyperplasias that developed following long-term activation. Studies using HC-11 mammary epithelial cells showed that iFGFR1-induced expression of the macrophage chemoattractant osteopontin was required for macrophage recruitment in vitro. Finally, conditional depletion of macrophages inhibited iFGFR1-mediated epithelial cell proliferation and lateral budding. These findings show that inflammatory cells, specifically macrophages, are critical for mediating early events in an inducible transgenic mouse model of preneoplastic progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740705     DOI: 10.1158/0008-5472.CAN-05-3781

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

1.  The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

Authors:  Raghib Ali; Han-Chong Toh; Whay-Kuang Chia
Journal:  Trials       Date:  2011-12-14       Impact factor: 2.279

Review 2.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

3.  Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.

Authors:  Adam C Pond; Jason I Herschkowitz; Kathryn L Schwertfeger; Bryan Welm; Yiqun Zhang; Brian York; Robert D Cardiff; Susan Hilsenbeck; Charles M Perou; Chad J Creighton; Richard E Lloyd; Jeffrey M Rosen
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 4.  Mammary gland macrophages: pleiotropic functions in mammary development.

Authors:  Kathryn L Schwertfeger; Jeffrey M Rosen; Donald A Cohen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

5.  The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis.

Authors:  Cheng-Yu Ko; Lanxiao Wu; Ashwin M Nair; Yi-Ting Tsai; Victor K Lin; Liping Tang
Journal:  Biomaterials       Date:  2011-10-22       Impact factor: 12.479

6.  PVT1 dependence in cancer with MYC copy-number increase.

Authors:  Yuen-Yi Tseng; Branden S Moriarity; Wuming Gong; Ryutaro Akiyama; Ashutosh Tiwari; Hiroko Kawakami; Peter Ronning; Brian Reuland; Kacey Guenther; Thomas C Beadnell; Jaclyn Essig; George M Otto; M Gerard O'Sullivan; David A Largaespada; Kathryn L Schwertfeger; York Marahrens; Yasuhiko Kawakami; Anindya Bagchi
Journal:  Nature       Date:  2014-06-22       Impact factor: 49.962

7.  The FGF/FGFR axis as a therapeutic target in breast cancer.

Authors:  Nicholas Brady; Polly Chuntova; Lindsey K Bade; Kathryn L Schwertfeger
Journal:  Expert Rev Endocrinol Metab       Date:  2013-07

Review 8.  Biomarkers and the genetics of early neoplastic lesions.

Authors:  Sudhir Srivastava; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

9.  Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation.

Authors:  Laura R Bohrer; Pavlina Chuntova; Lindsey K Bade; Thomas C Beadnell; Ronald P Leon; Nicholas J Brady; Yungil Ryu; Jodi E Goldberg; Stephen C Schmechel; Joseph S Koopmeiners; James B McCarthy; Kathryn L Schwertfeger
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

10.  Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis.

Authors:  Johanna R Reed; Ronald P Leon; Majken K Hall; Kathryn L Schwertfeger
Journal:  Breast Cancer Res       Date:  2009-04-24       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.